I tend to agree that everything now hinges on the commercial partner.... This is the news that will send this one to the moon... Or to the rubbish tip....
There is a possibility however that the BIG PHARMA's have teams involved with the human trial to assess its efficacy first hand...
So it is possible that Pharma due dilligence is linked to the Euro trials...
IMO 2011 is the year Vitro Gro will be commercially launched... Won't take long passed that to be the treatment of choice for all venous and diabetic ulcers moving forward...
TIS Price at posting:
66.6¢ Sentiment: Hold Disclosure: Held